OTTAWA, July 28, 2017 /CNW/ -
Issue
Health Canada is advising Canadians that "Selekta Pregnenolone," an unauthorized prescription product sold online at www.antyler.com, may pose serious health risks. Health Canada seized the product from the company, A.N. Tyler Distributing.
Selekta Pregnenolone was being promoted for anti-aging, arthritis, depression, menopause, mental fatigue, premenstrual syndrome, prostate disorders, skin irritation, scleroderma stress, women's health and supporting the immune system.
Who is affected
Affected product
What consumers should do
Background
Pregnenolone is a prescription drug that should only be used under the supervision of a healthcare professional. Pregnenolone can cause higher than normal levels of female and male hormones in the body and could increase the risk of prostate, breast, ovarian and other hormone-sensitive cancers. Pregnenolone should not be used by women who are pregnant or breast-feeding, and should be avoided by individuals who suffer from epileptic seizures or who are taking anti-seizure medications.
What Health Canada is doing
Health Canada seized the product from the company, A.N. Tyler Distributing. The company has agreed to stop selling and to recall the unauthorized product. Health Canada will monitor the company's recall. Should additional retailers or distributors be identified, Health Canada will take appropriate action and inform Canadians as necessary.
Related Links
For more information
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.
Également disponible en français
SOURCE Health Canada
Media Enquiries: Health Canada, (613) 957-2983; Public Enquiries: (613) 957-2991, 1-866 225-0709
Share this article